Sanctuary Advisors’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
TCM
HI
DGM
VPC
JT
ACM
CP
Sanctuary Advisors's ABVX Position: Q2 2026 in Review
Sanctuary Advisors increased its Abivax (ABVX) stake by 136% in Q2 2026, buying an estimated $346K and bringing the position to 5,300 shares worth $706K. The position accounts for ﹤0.01% of the portfolio, ranked #1712.
Sanctuary Advisors first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.
- Sanctuary Advisors held 5,300 shares of Abivax worth $706K as of Q2 2026.
- Sanctuary Advisors bought 3,053 Abivax shares in Q2 2026, an estimated $346K.
- Abivax made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1712 holding.
- Sanctuary Advisors first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
- 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.
Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.